Role of Cell-Cycle Proliferation Test, Triple Hit Phenotype, and TMPRSS2-ERG Expression to Evaluate the Risk of Progression in Prostate Cancer Patients Under Active Surveillance.

Oderda M, Orlando G, Calleris G, Capella G, Delsedime L, Duregon E, di Celle PF, Pacchioni D, Bonapace IM, Zaibunnisa Z, D'Agate D, Montefusco G, Filippini C, Papotti M, Gontero P

Open source

DOI
10.1002/pros.24921
Published
2025 Sep
Container
The Prostate
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/pros.24921,
  title = {Role of Cell-Cycle Proliferation Test, Triple Hit Phenotype, and TMPRSS2-ERG Expression to Evaluate the Risk of Progression in Prostate Cancer Patients Under Active Surveillance.},
  author = {Oderda M and Orlando G and Calleris G and Capella G and Delsedime L and Duregon E and di Celle PF and Pacchioni D and Bonapace IM and Zaibunnisa Z and D'Agate D and Montefusco G and Filippini C and Papotti M and Gontero P},
  year = {2025},
  journal = {The Prostate},
  doi = {10.1002/pros.24921},
  url = {https://doi.org/10.1002/pros.24921}
}

RIS

TY  - JOUR
TI  - Role of Cell-Cycle Proliferation Test, Triple Hit Phenotype, and TMPRSS2-ERG Expression to Evaluate the Risk of Progression in Prostate Cancer Patients Under Active Surveillance.
AU  - Oderda M
AU  - Orlando G
AU  - Calleris G
AU  - Capella G
AU  - Delsedime L
AU  - Duregon E
AU  - di Celle PF
AU  - Pacchioni D
AU  - Bonapace IM
AU  - Zaibunnisa Z
AU  - D'Agate D
AU  - Montefusco G
AU  - Filippini C
AU  - Papotti M
AU  - Gontero P
PY  - 2025
JO  - The Prostate
DO  - 10.1002/pros.24921
UR  - https://doi.org/10.1002/pros.24921
ER  - 

APA

M, O., G, O., G, C., G, C., L, D., E, D., PF, D. C., D, P., IM, B., Z, Z., D, D., G, M., C, F., M, P., & P, G. (2025). Role of Cell-Cycle Proliferation Test, Triple Hit Phenotype, and TMPRSS2-ERG Expression to Evaluate the Risk of Progression in Prostate Cancer Patients Under Active Surveillance.. The Prostate. https://doi.org/10.1002/pros.24921

Source records